SCHEMBL958741

SCHEMBL958741

Cc1cccc(C(C)(c2cccc(C)n2)c2cccc(C)n2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 2/20 0.50
CCR8 P51685 1/20 0.50
NOS3 P29474 1/20 0.46
NOS2 P35228 1/20 0.46
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
HPGD P15428 3/20 0.40
HSD17B10 Q99714 1/20 0.40
RAB9A P51151 5/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPC1 O15118 3/20 0.36
GRM5 P41594 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
HDAC6 Q9UBN7 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
PKM P14618 2/20 0.36
CYP2C19 P33261 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31688118 0.86 GRM5 (0.47) CCR1CCR8NOS3NOS2ALDH1A1
SCHEMBL5348383 0.86 CCR1 (0.39) CCR1CCR8NOS3NOS2ALDH1A1
SCHEMBL15004387 0.86 GRM5 (0.47) CCR1CCR8NOS3NOS2ALDH1A1
SCHEMBL77262 0.85 CCR1 (0.50) CCR1CCR8NOS3NOS2ALDH1A1
SCHEMBL29380771 0.85 CCR1 (0.50) CCR1CCR8NOS3NOS2ALDH1A1
SCHEMBL13821747 0.85 CCR1 (0.50) CCR1CCR8NOS3NOS2ALDH1A1
SCHEMBL25458041 0.83 CCR1 (0.48) CCR1CCR8NOS3NOS2ALDH1A1
SCHEMBL20031356 0.81 CCR1 (0.46) CCR1CCR8NOS3NOS2ALDH1A1
SCHEMBL20909878 0.81 CCR1 (0.46) CCR1CCR8NOS3NOS2ALDH1A1
SCHEMBL20892192 0.81 CCR1 (0.46) CCR1CCR8NOS3NOS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101981043-B Metal complexes MERCK PATENT GMBH 2014-11-05 CN disclosed
US-8617723-B2 Metal complexes MERCK PATENT GMBH (DE) 2013-12-31 US disclosed
US-20110012100-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110012100-A1 METAL COMPLEXES AP1M1, AP3M1, SOD1 CCR1 1608/4885CCR8 3259/4885NOS3 2431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.